Effects of a Tripeptide on Mitogen-Activated Protein Kinase and Glycogen Synthase Kinase Activation in a Cell Line Derived from the Foetal Hippocampus of a Trisomy 16 Mouse: an Animal Model of Down Syndrome-Reference-Cited by-同舟云学术

Effects of a Tripeptide on Mitogen-Activated Protein Kinase and Glycogen Synthase Kinase Activation in a Cell Line Derived from the Foetal Hippocampus of a Trisomy 16 Mouse: an Animal Model of Down Syndrome

Published:2019-12-04 Issue:3 Volume:37 Page:714-723
ISSN:1029-8428
Container-title:Neurotoxicity Research
language:en
Short-container-title:Neurotox Res

Author:

Arora Tushar,Caviedes Pablo,Sharma Shiv Kumar^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Toxicology,General Neuroscience

Link

http://link.springer.com/content/pdf/10.1007/s12640-019-00130-x.pdf

Reference42 articles.

1. Adams JP, Sweatt JD (2002) Molecular psychology: roles for the ERK MAP kinase cascade in memory. Annu Rev Pharmacol Toxicol 42:135–163. https://doi.org/10.1146/annurev.pharmtox.42.082701.145401

2. Ahmed MM, Dhanasekaran AR, Tong S, Wiseman FK, Fisher EMC, Tybulewicz VLJ, Gardiner KJ (2013) Protein profiles in Tc1 mice implicate novel pathway perturbations in the Down syndrome brain. Hum Mol Genet 22:1709–1724. https://doi.org/10.1093/hmg/ddt017

3. Bradley CA, Peineau S, Taghibiglou C, Nicolas CS, Whitcomb DJ, Bortolotto ZA Kaang B, Cho K, Wang Y and Collingridge GL (2012) A pivotal role of GSK-3 in synaptic plasticity. Front Mol Neurosci 5:13. https://doi.org/10.3389/fnmol.2012.00013

4. Burgos-Ramos E, Martos-Moreno GA, López MG, Herranz R, Aguado-Llera D, Egea J Frechilla D, Cenarruzabeitia E, León R, Arilla-Ferreiro E, Argente J, Barrios V (2009) The N-terminal tripeptide of insulin-like growth factor-I protects against beta-amyloid-induced somatostatin depletion by calcium and glycogen synthase kinase 3 beta modulation. J Neurochem 109:360–370. https://doi.org/10.1111/j.1471-4159.2009.05980.x

5. Cacciatore I, Cornacchia C, Baldassarre L, Fornasari E, Mollica A, Stefanucci A, Pinnen F (2012) GPE and GPE analogues as promising neuroprotective agents. Mini Rev Med Chem 12:13–23. https://doi.org/10.2174/138955712798868995

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Reduction in Hippocampal Amyloid-β Peptide (Aβ) Content during Glycine-Proline-Glutamate (Gly-Pro-Glu) Co-Administration Is Associated with Changes in Inflammation and Insulin-like Growth Factor (IGF)-I Signaling;International Journal of Molecular Sciences;2024-05-24

2. Concise Overview of Glypromate Neuropeptide Research: From Chemistry to Pharmacological Applications in Neurosciences;ACS Chemical Neuroscience;2023-02-03

3. Toxicity of Glycyl-l-Prolyl-l-Glutamate Pseudotripeptides: Cytotoxic, Oxidative, Genotoxic, and Embryotoxic Perspectives;Journal of Toxicology;2022-11-19

4. Therapeutic Potential of Ferulic Acid in Alzheimer's Disease;Current Drug Delivery;2021-12-28

5. Ketotic hypoglycemia in patients with Down syndrome;JIMD Reports;2021-07-28